Comparative Phase IV Study: Efficacy And Safety of TiTAN2 Versus COBALT-CHROME Stents- EVIDENCEII
A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 1350 participants.
Also called NCT01918150
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 1,350 participants
- Sponsor
- Hexacath, France
- Registry
-
NCT01918150
-
- Start date
- (registry gives no type)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- France
- Registry status
- Unknown status
Technical summary
Registry record NCT01918150. Randomized; single masking; primary purpose treatment. Start 2011-03 (registry gives no type); primary completion 2015-12 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Comparative Phase IV Study: Efficacy And Safety of TiTAN2 Versus COBALT-CHROME Stents- EVIDENCEII
- Acronym
- EVIDENCE II
- Condition
- Silent Myocardial Infarction
- Condition
- Stable Angina
- Condition
- Acute Coronary Syndrome
- Intervention (Device)
- Titan 2 stents
- Intervention (Device)
- Cobalt-Chromium Bare Metal Stents
- Lead sponsor
- Hexacath, France
Record details
- Record id
cardio:ct-nct01918150- Content hash
c7ded09db430504ccb3a448ee22717a0f884dbc6e6be97091c6fa4858a8fb132